Moreover, although it cannot be excluded that the exclusive right may have influenced the profitability of Teracom and, therefore, of the shareholder contribution to a certain extent, this cannot be established with certainty since Teracom is subject to price regulation — as explained above in paragraphs 42, 43 and 102 — and cannot freely exercise its market power. In the present case, it can, therefore, not be demonstrated that it is primarily because of the exclusive right that the shareholder contribution was a profitable investment. It can therefore also not be determined that, without the exclusive right, the expected return on the shareholder contribution would not have been acceptable to a private investor.
122 8. ASSESSMENT OF THE ALLEGED AID MEASURES › 8.3. The capital injection, Decision_act (EU) 2007/258
In forcesince 20 Dec 2006